Sour grapes. But at least Professor Krammer is being objective.
Another advantage of the inactivated vaccines being developed by Sinopharm is that they tend to have fewer adverse effects after immunization, according to Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai in New York. He said more clarity on the trials in the Emirates would be welcome, but expressed confidence in the vaccine’s initial results.
“It would be great to see some of that data,” Professor Krammer said in an email. “But 86 percent is a respectable number — there is absolutely nothing wrong with that. I would take such a vaccine.”
Another advantage of the inactivated vaccines being developed by Sinopharm is that they tend to have fewer adverse effects after immunization, according to Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai in New York. He said more clarity on the trials in the Emirates would be welcome, but expressed confidence in the vaccine’s initial results.
“It would be great to see some of that data,” Professor Krammer said in an email. “But 86 percent is a respectable number — there is absolutely nothing wrong with that. I would take such a vaccine.”